SBIR Phase I: A Wearable for Remote Monitoring of the COVID-19 Patient Population

SBIR 第一阶段：用于远程监控 COVID-19 患者群体的可穿戴设备

• 批准号: 2031714
• 负责人: Alireza Akhbardeh
• 金额: $ 25.6万
• 依托单位: CEREVU MEDICAL, INC.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-01 至 2021-05-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2031714&HistoricalAwards=false
• 关键词: SBIR; Phase; Wearable; Remote; Monitoring

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop real-time monitoring of COVID-19 symptoms toward public health objectives. This project will provide healthcare systems the ability to remotely manage patients during quarantine, protecting hospitals and healthcare workers from unnecessary visits that can quickly overwhelm the healthcare system. This remote monitoring will allow for early identification of patients requiring hospitalization by continuously monitoring key symptoms and notifying patients, caregivers, and loved ones when urgent care is required. This Small Business Innovation Research (SBIR) Phase I project is to integrate a forehead patch, smartphone/tablet app, firmware, and cloud-based data portal to continuously assess and monitor COVID-19 patients. The first step will be to develop firmware to measure and display key COVID-19 symptoms, such as changes in SpO2/hypoxia, heart rate, respiration rate, and body temperature. The system will also monitor vital signs including dyspnea, myalgia, coughing frequency, and coughing intensity. The monitor user interface will capture non-measurable patient inputs, such as consumption of fluids and food, gastric problems, changes in smell and taste capabilities, and medication usage. Rule-based alert algorithms will be developed to provide notifications to healthcare professionals when critical condition thresholds have been triggered. A datahub and physician dashboard will be developed to remotely monitor large groups of COVID-19 patients.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这项小型企业创新研究（SBIR）第一阶段项目的更广泛影响/商业潜力是开发对COVID-19症状的实时监测，以实现公共卫生目标。该项目将为医疗系统提供在隔离期间远程管理患者的能力，保护医院和医疗工作者免受可能很快使医疗系统不堪重负的不必要的访问。 这种远程监测将允许通过持续监测关键症状并在需要紧急护理时通知患者，护理人员和亲人来早期识别需要住院的患者。 这个小型企业创新研究（SBIR）第一阶段项目将整合前额贴片，智能手机/平板电脑应用程序，固件和基于云的数据门户，以持续评估和监测COVID-19患者。 第一步将是开发固件来测量和显示关键的COVID-19症状，如SpO 2/缺氧、心率、呼吸率和体温的变化。 该系统还将监测生命体征，包括呼吸困难、肌痛、咳嗽频率和咳嗽强度。监护仪用户界面将捕获不可测量的患者输入，例如液体和食物的消耗、胃病、嗅觉和味觉能力的变化以及药物使用。将开发基于规则的警报算法，以便在触发危急状况阈值时向医疗保健专业人员提供通知。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。